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In this study, the influence of surface morphology and wet- 
tability of both degradable and nondegradable polymer 
films on the inflammatory response after subcutaneous im- 
plantation in the rat was investigated. Degradable non- 
porous, porous, and "combi" (porous with a nonporous 
layer on one side) poly(L-lactic acid) (PLLA) films and non- 
degradable polytetrafluoroethylene (PTFE) and (porous) 
expanded PTFE (e-PTFE) were used. Contact angles mea- 
surements indicate that PLLA is more hydrophillic than 
PTFE. Assessment of the inflammatory response was per- 
formed after various periods of implantation (up till 180 
days), with both conventional light microscopy and immu- 
nohistochemistry using monoclonal antibodies (mAbs). 
The inflammatory response observed initially can largely be 
considered as part of the wound healing reaction, and up 
till day 40 the inflammatory response against PLLA was 
minimally more intense than against PTFE (porous as well 
as nonporous). From day 40 on, the PLLA films provoke a 
more intense inflammatory response as compared to the 
PTFE films. Both porous PLLA and the porous side of the 
"combi" PLLA film provoke a more intense inflammatory 
response than nonporous PLLA and the nonporous side of 
the "combi" PLLA film, respectively. In general, PTFE and 
e-PTFE films provoke an inflammatory response which is 
minimally more intense than the one provoked by the sham 
operation. Almost no ingrowth of tissue was observed in 
the porous e-PTFE films. In contrast, there was abundant 
tissue ingrowth in and an inflammatory response against 
porous PLLA. It can be concluded that biodegradable PLLA 
films provoke a more intense inflammatory response than 
nondegradable PTFE films. Also, porosity enhances the in- 
flammatory response. However, porosity enhances the in- 
flammatory response only when the wettability of a bioma- 
terial permits cellular ingrowth. 1995 John Wiley & Sons, 
Inc. 
INTRODUCTION 
Upon implantation of polymers, local'I2 and sys- 
temic3 effects can be observed. The local tissue reac- 
tion consists of an inflammatory response which 
serves to eliminate the cause of an injury, minimize 
the damage, and trigger mechanisms for repairing 
the tissue damaged by injury. The surgical procedure 
initially determines the type and intensity of the in- 
flammatory response. However, in addition, im- 
planted polymers themselves provoke an inflamma- 
tory response.* The characterization of and research 
on the factors determining this response can lead to 
new strategies for minimizing the inflammatory re- 
sponse against implanted polymers. 
*To whom correspondence should be addressed. 
Surface morphology is one of the factors influencing 
the inflammatory response against the biomaterial. 
This is indicated in various ~ t u d i e s . ~ , ~  Matlaga et al. 
demonstrated the roIe of shape.6 The intensity of the 
inflammatory response increases when the number 
of edges of the implanted materials increases. Also, 
there are studies indicating that the inflammatory re- 
sponse against implanted porous polymers or bioma- 
terials is more intense when compared to nonporous 
materials. 
Wettability may influence the tissue reaction to the 
polymer, because there is a range in wettability val- 
ues that is optimal for cell adhesion, growth, and 
spreading. Cells attach and proliferate less well on 
polymers having a wettability which is too low8 or too 
high.g 
Another factor is degradability. Degrading polymers 
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provoke a more intense inflammatory response com- 
pared to nondegrading polymers. A possible cause 
for this observation may be the release of monomers, 
oligomers, and/or fragments upon degradation."," 
However, at earlier stages of the degradation process, 
changes (such as an increase) in the surface morphol- 
ogy of a polymer (film) may occur, which in turn may 
alter the inflammatory response. 
In this paper, the (combined) influence of these 
factors were studied. Therefore, degradable and non- 
degradable polymer films, having a different porosity 
and wettability, were implanted subcutaneously in 
the back of the rat and the tissue reaction against 
them was evaluated. As biodegradable polymer, 
poly(L-lactic acid) (PLLA) was chosen because it has 
many (potential) As nondegradable, more 
hydrophobic polymer, nonporous and porous poly- 
tetrafluoroethylene (PTFE and e-PTFE, respectively) 
were chosen because polytetrafluoroethylene is con- 
sidered to be biologically inert and nondegrad- 
able. I4 , l5  
The inflammatory response was characterized us- 
ing semi-quantitative techniques comprising mor- 
phological criteria and monoclonal antibodies di- 
rected against epitopes which are specific for the re- 
spective cell types. 
MATERIALS AND METHODS 
Materials 
Poly(L-lactic acid) films were cast from PLLA with a 
reported Mv of 50,000 (Purac Biochem B.V., The 
Netherlands).16 Three types of films were cast: a non- 
porous type, a porous type, and a "combi" type (po- 
rous with a nonporous layer on one side), according 
to procedures described previously. l7 The base pa- 
rameters of the PLLA films are listed in Table I. All 
PLLA films were cut in strips of 15 x 2 mm. 
Polytetrafluoroethylene (PTFE) was obtained com- 
mercially (Wientjes, The Netherlands). PTFE was cut 
into strips of 15 x 2 x 1 mm. 
Expanded polytetrafluoroethylene (e-PTFE) was 
TABLE I 
Base Parameters of the PLLA Films 
Parameter PLLA film PLLA film PLLA film 
Nonporous Porous Combi 
~~ ~ 
Mw 98,000 109,000 167,000 
Mn 42,000 41,000 53,000 
MwiMn 2.3 2.7 3.1 
Tm 176 "C 180 "C 181 "C 
Heat of fusion 53 Jig 51 J/g 50 J/g 
obtained as nonsterile GORE-TEXR e-PTFE cell collec- 
tor tubing (WL Gore & Associates GMBH, Germany). 
The tubing was cut open along the longitudinal axis 
to obtain films measuring 15 x 2 x 0.25 mm. 
Except for PTFE, the final thickness of the films was 
determined with scanning electron microscopy 
(SEM). All films were cleaned by washing in a phos- 
phate buffered saline (PBS) for 24 h prior to use. 
Surface morphology 
Specimens of all films were sputter-coated with 
gold (Balzers 07 120B) and their surface morphology 
was examined with a DS 130 scanning electron mi- 
croscope (SEM) (ISI), operated at 10 kV. 
Wettability 
Wettability was determined by contact angle mea- 
surements using the sessile drop technique described 
by Busscher et al.'* For PTFE and the nonporous 
PLLA, the contact angles were determined using 
H 2 0  and a-bromonaphthalene as wetting agents. 
Five measurements were made for each polymer and 
wetting agent. 
Cytotoxicity 
To detect possible cytotoxicity prior to implanta- 
tion, films were tested in a direct contact test using a 
human skin fibroblasts cell line. The fibroblasts were 
cultured in 25 cm2 T-Flasks (Greiner, The Nether- 
lands) using RPMI 1640 medium (Gibco Europe B.V., 
The Netherlands) supplemented with 15% fetal calf 
serum (Gibco) and 100 IU/ml penicillidstreptomycin 
(Sigma) (Brunswick, The Netherlands) in humidified 
air with 5% CO, at 37°C. Every two days, the cultures 
were subdivided, using trypsin 0.05% in Ca2+/Mg2+ 
free phosphate buffered saline (PBS). 
The films were disinfected by immersion in ethanol 
70% for 1 min and air-dried under sterile conditions 
in a laminar flow cabinet. Subsequently, polymer 
films were mounted on the bottom of a well of a six 
well tissue culture polystyrene plate (Greiner). Three 
mL medium, containing approximately 5.104 cells, 
was added to each well. One well without polymer 
film (tissue culture polystyrene) served as a negative 
control. The medium was changed every fourth day. 
Cell cultures were evaluated qualitatively for signs 
of cell lysis, formation of an inhibition zone, and/or 
change in cell morphology for up till 12 days. 
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Implantation procedure 
The films were disinfected as described above prior 
to implantation and implanted subcutaneously in 21 
female (AOxBN)F, rats obtained from our own breed- 
ing facility. The films were implanted according to 
procedures described previously.16 In each rat a non- 
porous PLLA film, a porous PLLA film, a “combi” 
PLLA film, PTFE film, and an e-PTFE film were im- 
planted. The sixth incision and subcutaneous pocket 
served as a control (sham operation). Three samples 
per polymer and time interval were implanted. The 
rats had free access to standard rat food and water. 
All national rules concerning the care and use of lab- 
oratory animals have been observed. 
The rats were sacrificed after 1, 3, 7, 14, 40, 90, or 
180 days and the polymer films were removed with 
excess surrounding tissue. 
Evaluation of the inflammatory response 
Light microscopy 
After harvesting, the samples were immediately 
fixed for at least 24 h at 4°C in a 0.1 M Na-cacodylate 
buffer, pH 7.4, containing 2% glutaraldehyde and 0.1 
M sucrose. The samples were then dehydrated in a 
graded ethanol series and embedded in glycol- 
methacrylate (TechnovitB, Kulzer, Germany), allow- 
ing sections to be cut perpendicular to the longitudi- 
nal axis of the polymer film. Sections for lightmicro- 
scopical examination were cut on a microtome (Jung 
autocut 1140, equipped with a D knife with a tung- 
sten carbide cutting edge), mounted on glass slides, 
and stained with toluidine blue and alkaline 
fuchsin. l9 
Immunohistochemical staining 
After harvesting, samples were snap-frozen at 
-80°C using liquid freon. Cryostat sections of 7 p.m 
were cut, mounted on glass slides, air-dried, and 
fixed in acetone for 12 min. The sections were then 
again air-dried for 1 h and incubated with the first- 
stage, cell type specific, monoclonal antibody (mAb) 
for 1 h. Subsequently, the sections were washed 3 
times in PBS, followed by incubation with the sec- 
ond-stage antibody conjugated to peroxidase, diluted 
1:40 in PBS, and supplemented with 5% v/v normal 
rat serum to prevent nonspecific binding. Swine anti- 
rabbit Ig (Dakopatts, Denmark) was used as second- 
stage antibody to detect the first-stage mAb a-Asialo 
GM, (Table 11). Rabbit anti-mouse Ig (Dakopatts, 
Denmark) was used to detect the other first-stage 
mAbs. After incubation with the second-stage anti- 
body, sections were rinsed 3 times in PBS for 5 min. 
Peroxidase activity was demonstrated by applying 
3,3-diaminobenzidine tetrahydrochloride (Sigma) at a 
concentration of 0.5 mg/mL in 0.05 M Tris-HC1 buffer 
(pH 7.6) containing 0.01% H202 for 10 min. After 
rinsing in fresh tap water, sections were counter- 
stained lightly with haematoxylin for 10 s. The sec- 
tions were then dehydrated using a graded ethanol 
series and xylene and subsequently covered with cov- 
erslips using DePeX (Gurr, BDH Ltd, England) 
mounting medium. In controls, PBS was used instead 
of the first-stage mAb. The first-stage mAbs used and 
their sources are shown in Table 11. 
TABLE I1 
Monoclonal Antibodies (mAbs) Used to Examine and Quantify the Inflammatory Response Against the Implanted 
Polymer Films” 
Monoclonal 
Antibody Epitope Subcutaneous Tissue: Ref. No. 
Mainly Characterizing Cell Type in 
ox 1 CD 45 All leucocytes 20 
HIS 48 Probably surface antigen Granulocytes 21 
OX 19 CD 5 T-lymphocytes 22 
HIS 40 IgM heavy chain B-lymphocyte subset likely to react first upon inflammatory 23 
ED 1 Lysosomal antigen Majority of macrophages. Probably associated with active 24 
ED 2 Surface antigen Subset macrophages. Probably associated with maturity. 24,25 
ED 3 Surface antigen Subset macrophages. Probably associated with 24,26 
a-Asialo GM1 Probably surface antigen Large granular lymphocytesinatural killer cells 27 
response 
phagocytosis. 
downregulation of inflammatory reaction 
HIS 19 MHC class I1 Activated tissue cells (fibroblast) IDC, Subset macrophage 28 
~ 
aSource of the mAbs: OX antibodies were a generous gift of the late Dr. A. F. Williams, Department of Biochemistry, 
University of Oxford, Great Britain; ED antibodies were a generous gift of Dr. C. D. Dijkstra, Department of Cell Biology, 
Free University Amsterdam, The Netherlands; HIS antibodies were made at our Department of Histology and Cell Biology 
and the Asialo antibody was obtained at BAKO, The Netherlands. 
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Quantification of the inflammatory response the polymer films per field of view counted. Four 
fields of view per section, two sections per sample 
and three samples for each period of implantation, 
polymer film and monoclonal antibody, respectively, 
were examined. The tissue reaction at the edges of 
the polymer films were excluded from evaluation, to 
avoid artifacts due to mechanical irritation. 
The magnification of the light microscope was set 
at 400 X when examining the sections stained using 
mAbs. The staining patterns of the tissue surround- 
ing or invading the polymer film was evaluated and 
the number of positive cells surrounding or invading 
Figure 1. Scanning electron micrographs of a cross-section of PLLA films. (A) nonporous, (B) "combi" (arrow head 
indicates the nonporous side), (C) porous. The thickness of the films is: nonporous, 33 km, porous, 244 pm, and "combi," 
82 km. The thickness of the nonporous layer of the "combi" film was approximately 5 pm. The pore size of the porous film 
vaned from approximately 1 to 150 pm and of the "combi" film from 1 to 50 pm. Bar indicates 22 pm. 
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The number of cells staining positively per field of Wettability 
view was classified as follows: 
grade 0 = no positive cells, 
1 = 1 to 5 positive cells per field of view, 
2 = 5 to 10 positive cells per field of view, 
3 = 10 to 25 positive cells per field of view, and 
4 = more than 25 positive cells per field of view. 
The average class of the 24 fields of view for each 
period of implantation, polymer film and monoclonal 
antibody, respectively, is reported. 
RESULTS 
Surface morphology 
The thickness of the polymers was calculated using 
SEM: nonporous: 33 pm [Fig. 1(A)], porous: 244 pm 
[Fig. l(C)] and the "combi" film: 82 pm [Fig. l(C)]. 
The nonporous layer of the "combi" film was approx- 
imately 5 pm. The pore size of the porous film varied 
from approximately 1 to 150 pm and of the "combi" 
film from 1 to 50 pm. PTFE was nonporous, having 
the same morphological appearance of the surface as 
the nonporous PLLA film. The thickness of the po- 
rous e-PTFE film was approximately 250 pm, with a 
fibril length of approximately 90 pm (Fig. 2). 
The highest value of each set of five measurements 
is maximally 5 degrees higher than the lowest value. 
Therefore, it was not relevant to determine the stan- 
dard deviation. The H,O contact angles were 101" for 
PTFE and 72" for nonporous PLLA, and the a-bro- 
monaphthalene contact angles were 66" for PTFE and 
23" for nonporous PLLA. This shows that nonporous 
PLLA has a less hydrophobic surface than PTFE. 
Cytotoxicity 
Neither cell death, nor the formation of cell growth 
inhibition zones were observed. The morphological 
appearance of the fibroblasts in all wells in which 
materials were tested was normal and not differing 
from the controls. Thus, there was probably no re- 
lease of large quantities of toxic products up till the 
end of the experiment at day 12. 
Evaluation of the inflammatory response 
Macroscopically, there were no signs of an infec- 
tion demonstrated by any of the rats. The results of 
Figure 2. 
mately 90 pm. Bar indicates 30 pm. 
Scanning electron micrograph of (porous) ePTFE. The fibril length (=distance between A and B) is approxi- 
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the semi-quantitative evaluation of the immunohisto- 
chemical staining to detect leucocytes (OX l), neutro- 
philic granulocytes (HIS 48), macrophages (ED 1, ED 
2, ED 3), T-lymphocytes (OX 19), vast majority of 
B-lymphocyte (HIS 40), natural killer cells (a-asialo 
GM,), cells expressing MHC class I1 antigen, such as 
activated fibroblasts (His 19) are demonstrated in Fig- 
ures 3(A) to (I), respectively. False positive cells were 
observed occasionally in PBS controls. This was due 
a ALL LEUCOCYTES (OX 1) 
C T-LYMPHOCYTES (OX 19) 
to endogenous peroxidase activity expressed only by 
neutrophilic granulocytes, since the staining pattern 
using HIS 48 corresponds with the pattern of endog- 
enous peroxidase activity. Moreover, cells expressing 
endogenous peroxidase activity can be well distin- 
guished, due to their more intense staining as com- 
pared to cells stained for mAbs. 
The concentration of B-lymphocytes [Fig. 3(D)] and 
the concentration of natural killer cells [Fig. 3(H)] was 
b NEUTROPHILS (HIS 48) 
d B-LYMPHOCYTES (HIS 40) 
Figure 3. The average class of 24 fields of view of the number of cells involved in the inflammatory response against the 
implanted polymer films, stained with different mAbs. Class criteria: grade 0 = no positive cells, grade 1 = 1 to 5 positive 
cells, grade 2 = 5 to 10 positive cells, grade 3 = 10 to 25 positive cells and grade 4 = more than 25 positive cells per field 
of view at an original magnification of 400X. The following mAbs were used: (A) OX 1, all leucocytes, (B) HIS 48, neutrophilic 
granulocytes, (C) OX 19, T-lymphocytes, (D) HIS 40, vast majority of B lymphocytes, (E) ED 1, vast majority of macro- 
phages, including multinuclear giant cells, (F) ED 2, subset (matureiresident) macrophages, (G) ED 3, subset macrophages, 
(H) a-Asialo GM,, natural killer cellsilarge granular lymphocytes, (I) HIS 19, cells expressing MHC I1 antigen, e.g., activated 
fibroblasts, macrophages, dendritic cells. X-axis represents implantation time (days). Y-axis the average number of cells per 
field of view as class 0 to 4. Z-axis represents the different polymer films. 
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to a large extent similar and low for both PLLA, PTFE 
films, and the subcutaneous tissue under the scar of 
the sham operation. 
At day 3, the concentration of each cell type in- 
volved in the inflammatory response as a measure for 
the intensity was approximately the same for all the 
polymers films [Fig. 3(A) to (G)]. 
At day 7, macrophages are beginning to play a 
prominent role in the inflammatory response [Fig. 
3(E)]. Subsets of macrophages surrounding the poly- 
mer films were found in different locations. ED 1 pos- 
itive macrophages are found in the entire area dem- 
onstrating inflammatory response against the im- 
plant, especially in the area in closest approximation 
of the polymer film [Fig. 4(A)]. In contrast, ED 2 and 
ED 3 positive macrophages are neither found in the 
area in closest approximation the polymer film, nor in 
the pores of the PLLA or PTFE film. ED 2 and ED 3 
positive macrophages remain restricted to the sur- 
rounding tissue at some distance from the implant 
[Fig. 4(B) and (C)]. The relative ratio between the sub- 
sets was fairly constant for the respective implants. 
In GMA sections it is observed that the inflamma- 
tory response at day 7 is becoming more intense for 
the porous PLLA and porous side of the "combi" 
PLLA films (Fig. 5). For the nonporous PLLA and the 
nonporous side of the "combi" PLLA film, the onset 
of encapsulation by approximately 3 layers of fibro- 
blasts was observed. Only a minimal encapsulation is 
observed for the porous PLLA film at day 7. 
In contrast to the porous PLLA film almost no cel- 
lular invasion of the e-PTFE film was observed. The 
cell layer surrounding e-PTFE consists mainly of mac- 
rophages. The PTFE film was surrounded by one or 
two layers of macrophages and the onset of encapsu- 
lation can be observed. 
At day 14, the inflammatory response becomes 
chronic with predominantly macrophages and T-lym- 
phocytes surrounding the films. In GMA sections, 
foreign body giant cells can be observed surrounding 
the PLLA films (Fig. 6). All films are now encapsu- 
lated by continuous layers of fibrocytes and collagen. 
The fibrocytes are not stained by HIS 19 monoclonal 
antibody, indicating a decrease in cell activity. 
The porous PLLA film and porous side of the 
"combi" film provokes a more intense inflammatory 
response than the nonporous PLLA film and non- 
porous side of the "combi" film, respectively. How- 
ever, this observation could not be made for the 
e-PTFE film as compared to the PTFE film. 
At day 40, in general, the intensity of the inflam- 
matory response against the polymer films had de- 
creased further. However, PLLA films still provoke a 
more intense inflammatory response than PTFE films 
as demonstrated by the higher concentration of neu- 
trophils, macrophages/giant cells, and T-lymphocytes 
surrounding the PLLA films [Fig. 3(B), (C), (E), (F), 
and (G)]. The concentration of cells against PTFE and 
e-PTFE films is comparable to the concentration of 
cells in the subcutaneous tissue under the scar of the 
sham operation. 
The inflammatory response against the nonporous 
PLLA film was mainly localized at the edges of the 
film or at the edges of the pieces when broken. In 
contrast, the inflammatory response against porous 
PLLA films was localized in the pores. The "combi" 
film shows a more pronounced inflammatory re- 
sponse at the porous side. 
At day 90, the difference in the intensity of the in- 
flammatory response between PLLA and PTFE films 
and also between nonporous and porous PLLA films 
had become much more pronounced. This is demon- 
strated by the increased concentration of macro- 
phages, leucocytes, and cells expressing MHC class I1 
(HIS 19) antigen, (probably activated fibroblasts) sur- 
rounding or invading the PLLA films. The porous 
PLLA films provokes a more intense inflammatory 
response than the nonporous PLLA film. In contrast, 
the inflammatory response against PTFE and e-PTFE 
films remained the same as at day 40. 
At day 180, the difference in the intensity of the 
inflammatory response between the nonporous and 
porous PLLA film was more pronounced. In contrast, 
the tissue reaction ("inflammatory response") against 
PTFE and e-PTFE did not differ much from the tissue 
reaction in the subcutaneous tissue under the scar of 
the sham operation. There are almost no cells local- 
ized in the pores of e-PTFE (Fig. 7). In contrast, the 
inflammatory response against porous PLLA was lo- 
calized in mainly the large pores. 
DISCUSSION 
Inflammatory response and biocompatibility 
The results demonstrate that there are two phases 
in the inflammatory response against the films. Phase 
1 is observed upon implantation of the film. It is 
mainly caused by the injury sustained by the implan- 
tation procedure. This uncomplicated inflammatory 
response, part of the wound healing reaction, ends 
after 7 to 10 days and has been well In 
this phase, the contribution of the implanted polymer 
film to the intensity of the inflammatory response is 
in most cases minimal, except when leakage of large 
quantities of toxic products occurs.3o After one week, 
any remaining inflammatory response can be consid- 
ered as a tissue reaction against the implanted bio- 
material.31 This chronic inflammatory response 
(phase 2) is often described as a foreign body reac- 
t i ~ n . ' , ' , ~ ~  It mainly consists of macrophages and giant 
cells surrounding the implant. 
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Figure 4. Immunohistochemical staining of the tissue surrounding the porous PLLA film (P) at day 7, with: (A) ED 1. The 
macrophages adjacent to the implant stain positive for ED 1. No ED 1 positive cells are observed in the polymer film. (9) 
ED 2 .  The macrophages adjacent to the implant do not stain positive for ED 2 .  The cells in the left lower corner stain false 
positive for ED 2.  This is due to endogenous peroxidase activity of neutrophilic granulocytes. (C) ED 3. The macrophages 
adjacent to the implant do not stain positive for ED 3. Bar indicates 40 km. 
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Figure 5. 
response between the porous and nonporous side. Bar indicates 40 p.m. 
"Combi" PLLA film (P) 7 days after implantation. Note the difference in the intensity of the inflammatory 
A minimal inflammatory response is preferred 
when biomaterials are implanted for a long time 
span, because a persistent (chronic) inflammatory re- 
sponse may predispose for a m y l o i d ~ s i s ~ ~ , ~ ~  or carci- 
n ~ g e n e s i s . ~ ~  A persistent inflammatory response in- 
creases the concentration of both serum arnyloid A 
(SAA) and amyloid enhancing factor (AEF) in blood. 
SAA may then be converted into amyloid A, which is 
deposited in tissues.32i33 However, the exact mecha- 
nism is yet to be fully uncovered and the relation 
between the chronic inflammatory response against 
biomaterials and amyloidosis also remains to be in- 
Figure 6. 
(arrow heads). Bar denotes 40 km. 
Nonporous PLLA film (P) 14 days after subcutaneous implantation. Note the large concentration of giant cells 
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Figure 7. (A) Porous e-PTFE (P) and (B) porous PLLA (P) after 180 days of implantation. There are almost no inflammatory 
cells localized in the pores of the e-PTFE film. In contrast, the inflammatory response is localized mainly in the large pores 
of the porous PLLA film. F = fibrous encapsulation. Bar indicates 63 km. 
vestigated. There are reports demonstrating a higher 
tumour incidence at the implantation site of PLLA35 
and other polymers36 in rats. However, the authors 
did not correlate their findings to an inflammatory 
response as they only indicated stimulation as a pos- 
sible cause. Therefore, the relation between chronic 
inflammatory response against polymers and carcino- 
genesis needs further investigation. 
The role of macrophages and giant cells 
ED 1 stains an intracellular antigen probably asso- 
ciated with the lysosomal membrane.24 The antigen 
probably remains present, even in the event of fusion 
of macrophages and formation of foreign body giant 
cells, since ED 1 positive cells are observed on the 
same location of foreign body giant cells in conven- 
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tional light microscopical sections. ED 2 is a marker 
which is found on mature tissue macrophages. It 
takes about one week for monocytes/macrophages to 
express ED 2 on their cell surface after leaving the 
vascular system.25 The role of ED 2 and ED 326 in the 
inflammatory response is not well understood. The 
different staining patterns of the ED antibodies indi- 
cate the possibility of either different populations of 
macrophages which play a role in the tissue reaction 
against biomaterials, or macrophages expressing dif- 
ferent surface receptors in the course of the inflam- 
matory response against a biomaterial. 
The exact mechanism of foreign body giant cell for- 
mation is still to be elucidated. Certain cell types, 
e.g., T-lymphocytes, may play a pivotal role in this 
process. Especially T-helper lymphocytes capable of 
secreting interferon-? may play a role in the fusion of 
macrophages, forming giant Activation of 
macrophages may be induced by various pathways. 
In one pathway, (limited) damage to neutrophils and 
macrophages may lead to secretion of cytokines (IL- 
l), activating T-helper lymphocytes. Another possi- 
bility is change of shape when a macrophage comes 
in contact with a b i ~ m a t e r i a l , ~ ~ , ~ '  especially when a 
single macrophage is not able to phagocytose the 
polymer (fragment). 
Porosity, wettability, degradability, and 
inflammatory response 
Porous PLLA provokes a more intense inflamma- 
tory response from day 7 on, despite a higher degra- 
dation rate of the nonporous PLLA in aqueous envi- 
ronment.I7 This indicates that porosity is an impor- 
tant factor determining the intensity of the 
inflammatory response against implanted PLLA 
films. The small difference in the intensity of the in- 
flammatory response between PTFE and e-PTFE as 
compared to nonporous and porous PLLA, respec- 
tively, indicates that porosity as a single factor is not 
enough to enhance the inflammatory response. The 
relatively high wettability of PLLA compared to 
e-PTFE allows for better ingrowth of tissue into the 
pores of PLLA and probably more exposure to other 
factors, determining the intensity of the inflamma- 
tory response. 
According to many authors, the surface properties 
of an implant have a large influence on the inflam- 
matory response.4143 Thus, the difference in wetta- 
bility as one of the surface properties may also be a 
factor, aIthough Baier et al. could not demonstrate a 
difference in the inflammatory response against 
smooth metal pieces having a different ~ e t t a b i l i t y . ~ ~  
However, other authors demonstrated that different 
polymers induces a different level of IL-1 production, 
correlating with the intensity of the inflammatory re- 
s p ~ n s e , ~ ~ ~  although the relation with wettability 
was not investigated. However, the production of 
IL-1 seems to be less when using relatively hydro- 
phobic materials such as silicon. Further investigation 
is needed to establish the precise relation between 
wettability and inflammatory response. 
The differences in inflammatory response against 
the PLLA (degradable) and PTFE (nondegradable) 
films became apparent from day 40. One reason may 
be the difference in the rate of degradation and sub- 
sequently the difference in the release of degradation 
products, such as monomers, oligomers, and finally 
fragments. As stated previously, only a few (mostly 
nonporous) PLLA films were observed to be broken 
into two or three pieces. However, there is probably 
also increase in surface area which could hardly be 
observed. Also, the size of the pores of the porous 
PLLA films has increased with possibly the same ef- 
fect as fragmentation. In the case of PLLA films, the 
increase in surface area during the degradation pro- 
cess as a single factor may be sufficient for increasing 
the intensity of the inflammatory response. 
It can be concluded that biodegradable PLLA films 
provoke a more intense inflammatory response than 
nondegradable PTFE films. Also, porosity enhances 
the inflammatory response. However, porosity en- 
hances the inflammatory response only when the 
wettability of a biomaterial permits cellular ingrowth. 
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